IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
December 2, 2020
Philadelphia, PA, December 2, 2020 – IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced charitable donations resulting from record sales in 2020. The company has donated $11,000 each to the American Cancer Society and Crisis Text Line. The donations resulted from a Sales initiative to target key charitable giving based on breaking sales records.
“As most companies do, we develop sales incentive programs that motivate our team to reach above and beyond,” said Gary Palgon, IntegriChain Senior Vice President, Sales, Enterprise Accounts. “What better incentive to surpass our sales records than the chance to make significant charitable contributions to outstanding organizations? We are thrilled to support the life-saving work of the American Cancer Society and Crisis Text Line with this program.”
“The American Cancer Society has never faced a threat to our mission like COVID-19, however our work is too important to cancer patients and families that rely on us,” said Paula Green, executive director of ACS of Greater Philadelphia. “We envision a future where our children will no longer live with the threat of cancer, and thanks to partners like IntegriChain and their generous employees, we are continuing to push towards that future.”
About the American Cancer Society The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is attacking cancer from every angle. The Society does not endorse any product or service. For more information go to www.cancer.org.
About Crisis Text Line Crisis Text Line provides free, 24/7, confidential support for people in crisis via text. Crisis Counselors complete a 30-hour training and have 24/7 supervision by full-time Crisis Text Line mental health professionals. In the US, text HELLO to 741741 to be connected with a trained Crisis Counselor, 24/7. Crisis Text Line launched in 2013 in the United States.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 250 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services, and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Webinars & Resources
See List
Register Today
